Total Valuation
Mesoblast Limited has a market cap or net worth of $2.51B. The enterprise value is $3.52K.
Market Cap$2.51B
Enterprise Value$3.52K
Share Statistics
Mesoblast Limited has 1,296,862,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,296,862,800
Owned by Insiders23.12%
Owned by Institutions0.01%
Financial Efficiency
Mesoblast Limited’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is -8.45%.
Return on Equity (ROE)-0.17
Return on Assets (ROA)-0.13
Return on Invested Capital (ROIC)-8.45%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee212.32K
Profits Per Employee-1.26M
Employee Count81
Asset Turnover0.02
Inventory Turnover0.23
Valuation Ratios
The current PE Ratio of Mesoblast Limited is ―. Mesoblast Limited’s PEG ratio is -27.18.
PE Ratio―
PS Ratio72.48
PB Ratio2.09
Price to Fair Value2.09
Price to FCF-24.59
Price to Operating Cash Flow-45.53
PEG Ratio-27.18
Income Statement
In the last 12 months, Mesoblast Limited had revenue of 17.20M and earned -102.14M in profits. Earnings per share was -0.09.
Revenue17.20M
Gross Profit12.07M
Operating Income-62.44M
Pretax Income-101.81M
Net Income-102.14M
EBITDA-73.66M
Earnings Per Share (EPS)-0.09
Cash Flow
In the last 12 months, operating cash flow was -59.76M and capital expenditures -1.11M, giving a free cash flow of -60.87M billion.
Operating Cash Flow-59.76M
Free Cash Flow-60.87M
Free Cash Flow per Share-0.05
Dividends & Yields
Mesoblast Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta<0.01
52-Week Price Change76.17%
50-Day Moving Average1.62
200-Day Moving Average1.60
Relative Strength Index (RSI)86.52
Average Volume (3m)69.00
Important Dates
Mesoblast Limited upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Mesoblast Limited as a current ratio of 1.99, with Debt / Equity ratio of 23.52%
Current Ratio1.99
Quick Ratio1.77
Debt to Market Cap0.10
Net Debt to EBITDA0.45
Interest Coverage Ratio-2.87
Taxes
In the past 12 months, Mesoblast Limited has paid 330.00K in taxes.
Income Tax330.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Mesoblast Limited EV to EBITDA ratio is -16.47, with an EV/FCF ratio of -23.94.
EV to Sales70.56
EV to EBITDA-16.47
EV to Free Cash Flow-23.94
EV to Operating Cash Flow-24.29
Balance Sheet
Mesoblast Limited has $129.57M in cash and marketable securities with $135.14M in debt, giving a net cash position of -$5.57M billion.
Cash & Marketable Securities$129.57M
Total Debt$135.14M
Net Cash-$5.57M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share$0.02
Margins
Gross margin is -53.34%, with operating margin of -363.08%, and net profit margin of -593.92%.
Gross Margin-53.34%
Operating Margin-363.08%
Pretax Margin-592.00%
Net Profit Margin-593.92%
EBITDA Margin-428.30%
EBIT Margin-465.51%
Analyst Forecast
The average price target for Mesoblast Limited is $2.68, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.68
Price Target Upside67.61% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast1053.16%
EPS Growth Forecast20.67%